Literature DB >> 33097575

Juvenile, but Not Adult, Mice Display Increased Myeloid Recruitment and Extracellular Matrix Remodeling during Respiratory Syncytial Virus Infection.

Gerald G Kellar1,2,3, Stephen R Reeves4,5, Kaitlyn A Barrow5, Jason S Debley4,5, Thomas N Wight2, Steven F Ziegler6,3.   

Abstract

Early life respiratory syncytial virus (RSV) infection has been linked to the onset of asthma. Despite this association, our knowledge of the progression of the initial viral infection is limited, and no safe or effective vaccine currently exists. Bronchioalveolar lavage, whole-lung cellular isolation, and gene expression analysis were performed on 3-wk- (juvenile) and 8-wk-old (adult) RSV-infected C57BL/6 mice to investigate age-related differences in immunologic responses; juvenile mice displayed a sustained myeloid infiltrate (including monocytes and neutrophils) with increased RNA expression of Ccl2, Ccl3, and Ccl4, when compared with adult mice, at 72 h postinfection. Juvenile mice demonstrated αSma expression (indicative of myofibroblast activity), increased hyaluronan deposition in the lung parenchyma (attributed to asthma progression), and a lack of CD64 upregulation on the surface of monocytes (which, in conjunction with serum amyloid P, is responsible for clearing residual hyaluronan and cellular debris). RSV infection of human airway epithelial cell, human lung fibroblast, and U937 monocyte cocultures (at air-liquid interface) displayed similar CCL expression and suggested matrix metalloproteinase-7 and MMP9 as possible extracellular matrix modifiers. These mouse data, in conjunction with our findings in human monocytes, suggest that the sustained influx of myeloid cells in the lungs of juvenile mice during acute RSV infection could potentiate extracellular matrix remodeling, facilitating conditions that support the development of asthma.
Copyright © 2020 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Year:  2020        PMID: 33097575      PMCID: PMC7747670          DOI: 10.4049/jimmunol.2000683

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  49 in total

Review 1.  Proteoglycans: key regulators of pulmonary inflammation and the innate immune response to lung infection.

Authors:  Sean Gill; Thomas N Wight; Charles W Frevert
Journal:  Anat Rec (Hoboken)       Date:  2010-06       Impact factor: 2.064

2.  Versican Deficiency Significantly Reduces Lung Inflammatory Response Induced by Polyinosine-Polycytidylic Acid Stimulation.

Authors:  Inkyung Kang; Ingrid A Harten; Mary Y Chang; Kathleen R Braun; Alyssa Sheih; Mary P Nivison; Pamela Y Johnson; Gail Workman; Gernot Kaber; Stephen P Evanko; Christina K Chan; Mervyn J Merrilees; Steven F Ziegler; Michael G Kinsella; Charles W Frevert; Thomas N Wight
Journal:  J Biol Chem       Date:  2016-11-28       Impact factor: 5.157

3.  Oligosaccharides of hyaluronan are potent activators of dendritic cells.

Authors:  C C Termeer; J Hennies; U Voith; T Ahrens; J M Weiss; P Prehm; J C Simon
Journal:  J Immunol       Date:  2000-08-15       Impact factor: 5.422

4.  Responsiveness to respiratory syncytial virus in neonates is mediated through thymic stromal lymphopoietin and OX40 ligand.

Authors:  Junyan Han; Azzeddine Dakhama; Yi Jia; Meiqin Wang; Wanjiang Zeng; Katsuyuki Takeda; Yoshiki Shiraishi; Masakazu Okamoto; Steven F Ziegler; Erwin W Gelfand
Journal:  J Allergy Clin Immunol       Date:  2012-10-01       Impact factor: 10.793

5.  Subepithelial Accumulation of Versican in a Cockroach Antigen-Induced Murine Model of Allergic Asthma.

Authors:  Stephen R Reeves; Gernot Kaber; Alyssa Sheih; Georgiana Cheng; Mark A Aronica; Mervyn J Merrilees; Jason S Debley; Charles W Frevert; Steven F Ziegler; Thomas N Wight
Journal:  J Histochem Cytochem       Date:  2016-04-28       Impact factor: 2.479

6.  A rapid increase in macrophage-derived versican and hyaluronan in infectious lung disease.

Authors:  Mary Y Chang; Yoshinori Tanino; Veronika Vidova; Michael G Kinsella; Christina K Chan; Pamela Y Johnson; Thomas N Wight; Charles W Frevert
Journal:  Matrix Biol       Date:  2014-01-26       Impact factor: 11.583

7.  CCL20/CCR6 blockade enhances immunity to RSV by impairing recruitment of DC.

Authors:  Lara E Kallal; Matthew A Schaller; Dennis M Lindell; Sergio A Lira; Nicholas W Lukacs
Journal:  Eur J Immunol       Date:  2010-04       Impact factor: 5.532

8.  Alveolar macrophage-derived type I interferons orchestrate innate immunity to RSV through recruitment of antiviral monocytes.

Authors:  Michelle Goritzka; Spyridon Makris; Fahima Kausar; Lydia R Durant; Catherine Pereira; Yutaro Kumagai; Fiona J Culley; Matthias Mack; Shizuo Akira; Cecilia Johansson
Journal:  J Exp Med       Date:  2015-04-20       Impact factor: 14.307

9.  Respiratory syncytial virus induced type I IFN production by pDC is regulated by RSV-infected airway epithelial cells, RSV-exposed monocytes and virus specific antibodies.

Authors:  Marcel A Schijf; Michael V Lukens; Debby Kruijsen; Nathalie O P van Uden; Johan Garssen; Frank E J Coenjaerts; Belinda Van't Land; Grada M van Bleek
Journal:  PLoS One       Date:  2013-11-26       Impact factor: 3.240

10.  Defective lung function following influenza virus is due to prolonged, reversible hyaluronan synthesis.

Authors:  Thomas J Bell; Oliver J Brand; David J Morgan; Samira Salek-Ardakani; Christopher Jagger; Toshifumi Fujimori; Lauren Cholewa; Viranga Tilakaratna; Jörgen Östling; Matt Thomas; Anthony J Day; Robert J Snelgrove; Tracy Hussell
Journal:  Matrix Biol       Date:  2018-06-20       Impact factor: 11.583

View more
  2 in total

Review 1.  Defining the versican interactome in lung health and disease.

Authors:  Fengying Tang; Jourdan E Brune; Mary Y Chang; Stephen R Reeves; William A Altemeier; Charles W Frevert
Journal:  Am J Physiol Cell Physiol       Date:  2022-06-01       Impact factor: 5.282

2.  The IRE1α-XBP1s Arm of the Unfolded Protein Response Activates N-Glycosylation to Remodel the Subepithelial Basement Membrane in Paramyxovirus Infection.

Authors:  Yingxin Zhao; Dianhua Qiao; Melissa Skibba; Allan R Brasier
Journal:  Int J Mol Sci       Date:  2022-08-12       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.